|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
86417
|
Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression.
|
Cell Commun Signal |
2025-12-17 |
Pubmed
Full text
|